Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,465 | 404 | 99.6% |
| Education | $23.33 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $815.10 | 63 | $0 (2021) |
| Novo Nordisk Inc | $682.24 | 49 | $0 (2022) |
| PFIZER INC. | $618.28 | 63 | $0 (2024) |
| GlaxoSmithKline, LLC. | $503.45 | 39 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $483.67 | 32 | $0 (2019) |
| Mylan Specialty L.P. | $455.91 | 33 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $327.27 | 22 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $326.99 | 28 | $0 (2021) |
| Amgen Inc. | $231.75 | 9 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $216.00 | 15 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.24 | 1 | PFIZER INC. ($16.24) |
| 2023 | $73.48 | 5 | GlaxoSmithKline, LLC. ($41.56) |
| 2022 | $209.70 | 12 | GlaxoSmithKline, LLC. ($96.32) |
| 2021 | $656.16 | 44 | Novo Nordisk Inc ($132.52) |
| 2020 | $149.47 | 10 | Sunovion Pharmaceuticals Inc. ($31.20) |
| 2019 | $1,046 | 76 | AstraZeneca Pharmaceuticals LP ($198.43) |
| 2018 | $1,668 | 127 | AstraZeneca Pharmaceuticals LP ($324.81) |
| 2017 | $1,669 | 133 | SANOFI-AVENTIS U.S. LLC ($288.73) |
All Payment Transactions
408 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: PAIN | ||||||
| 12/06/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardio-renal | ||||||
| 04/18/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: PAIN | ||||||
| 11/15/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Cardio-renal | ||||||
| 10/18/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Cardio-renal | ||||||
| 09/18/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/31/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Gastroenterology | ||||||
| 07/21/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/12/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: RESPIRATORY | ||||||
| 06/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: RESPIRATORY | ||||||
| 05/03/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Obesity | ||||||
| 04/26/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: RESPIRATORY | ||||||
| 04/05/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: RESPIRATORY | ||||||
| 03/10/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: RESPIRATORY | ||||||
| 12/08/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2021 | Sunovion Pharmaceuticals Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: UROLOGY | ||||||
| 11/09/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: RESPIRATORY | ||||||
| 11/03/2021 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/28/2021 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 3,683 | 5,075 | $401,060 | $138,284 |
| 2022 | 51 | 4,162 | 6,031 | $468,463 | $159,394 |
| 2021 | 61 | 4,506 | 6,572 | $485,839 | $171,279 |
| 2020 | 53 | 4,104 | 6,283 | $493,412 | $151,680 |
All Medicare Procedures & Services
213 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 353 | 601 | $135,009 | $42,471 | 31.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 280 | 563 | $86,702 | $30,961 | 35.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 83 | 83 | $6,640 | $6,292 | 94.8% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 36 | 51 | $4,284 | $4,186 | 97.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 20 | $9,742 | $4,119 | 42.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 279 | 295 | $11,800 | $3,862 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 32 | 32 | $7,830 | $3,830 | 48.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 212 | 223 | $12,588 | $3,671 | 29.2% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 35 | 39 | $5,850 | $3,661 | 62.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 302 | 334 | $11,690 | $3,457 | 29.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 60 | 70 | $10,500 | $3,419 | 32.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 302 | 420 | $10,500 | $3,174 | 30.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 103 | 105 | $5,772 | $2,945 | 51.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 161 | 290 | $15,941 | $2,472 | 15.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 16 | $7,793 | $2,243 | 28.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 68 | 73 | $4,015 | $2,118 | 52.7% |
| 80047 | Blood test, basic group of blood chemicals (calcium, ionized) | Office | 2023 | 93 | 117 | $2,762 | $1,557 | 56.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 103 | 146 | $4,380 | $1,377 | 31.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 58 | 74 | $4,830 | $1,296 | 26.8% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 18 | 26 | $2,470 | $975.47 | 39.5% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 131 | 216 | $6,480 | $918.04 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $4,507 | $823.20 | 18.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 276 | 370 | $2,320 | $810.58 | 34.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 42 | 42 | $2,310 | $756.84 | 32.8% |
| J2010 | Injection, lincomycin hcl, up to 300 mg | Office | 2023 | 65 | 102 | $2,040 | $659.85 | 32.3% |
About Dr. David Walt, MD
Dr. David Walt, MD is a Family Medicine healthcare provider based in Cleveland, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205895448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Walt, MD has received a total of $5,488 in payments from pharmaceutical and medical device companies, with $16.24 received in 2024. These payments were reported across 408 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,465).
As a Medicare-enrolled provider, Walt has provided services to 16,455 Medicare beneficiaries, totaling 23,961 services with total Medicare billing of $620,637. Data is available for 4 years (2020–2023), covering 213 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cleveland, MS
- Active Since 03/17/2006
- Last Updated 12/11/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1205895448
Products in Payments
- FARXIGA (Drug) $321.90
- ENTRESTO (Drug) $312.85
- Victoza (Drug) $264.61
- Yupelri (Drug) $259.28
- SOLIQUA (Drug) $232.16
- TRELEGY ELLIPTA (Drug) $209.22
- JARDIANCE (Drug) $195.39
- BEVESPI AEROSPHERE (Drug) $183.90
- Ozempic (Drug) $180.85
- TOUJEO (Drug) $177.80
- LONHALA MAGNAIR (Drug) $167.01
- TOVIAZ (Drug) $161.76
- BYDUREON (Drug) $160.52
- VIAGRA (Drug) $158.97
- Repatha (Biological) $151.68
- CHANTIX (Drug) $142.65
- ANORO (Drug) $141.24
- Dymista (Drug) $116.09
- BREO (Drug) $111.43
- Vascepa (Drug) $100.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cleveland
Dominic King, D.o, D.O
Family Medicine — Payments: $337,674
Jeannette Potts, Md, MD
Family Medicine — Payments: $30,044
Meaghan Combs, Md, MD
Family Medicine — Payments: $25,727
George Stokes, Md, MD
Family Medicine — Payments: $18,678
Dr. Charles Brock, M.d, M.D
Family Medicine — Payments: $9,519
Mr. Cecil Breetzke, Md, MD
Family Medicine — Payments: $9,499